Výsledky vyhledávání - Huixing Yuan

  • Zobrazuji výsledky 1 - 5 z 5
Upřesnit hledání
  1. 1
    Atractylenolide I ameliorated the growth and enzalutamide resistance of castration-resistant prostate cancer by targeting KIF15

    Atractylenolide I ameliorated the growth and enzalutamide resistance of castration-resistant prostate cancer by targeting KIF15 Autor Chenglin Han, Bin Yang, Yuxuan Deng, Hu Peng, Bintao Hu, Xiaming Liu, Tao Wang, Chengbao Li, Jihong Liu, Huixing Yuan

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Perioperative Management of Hemostasis with Recombinant FIX Fc Fusion Protein in Subjects Undergoing Surgery in the B-YOND Study

    Perioperative Management of Hemostasis with Recombinant FIX Fc Fusion Protein in Subjects Undergoing Surgery in the B-YOND Study Autor Margareth C. Ozelo, Johnny Mahlangu, Godfrey Chi Fung Chan, Margareta Holmström, Nicolás Novitzky, David J. Perry, Huixing Yuan, Lynda M. Cristiano, Baisong Mei

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

    Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study Autor Beatrice Nolan, Johnny Mahlangu, Ingrid Pabinger, Guy Young, Barbara A. Konkle, Chris Barnes, Keiji Nogami, Elena Santagostino, John Pasi, Liane Khoo, Bent Winding, Huixing Yuan, Joachim Fruebis, Dan Rudin, Johannes Oldenburg

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study

    Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extensio... Autor John Pasi, Kathelijn Fischer, Margaret V. Ragni, Roshni Kulkarni, Margareth C. Ozelo, Johnny Mahlangu, Amy D. Shapiro, Stephanie P’ng, Hérvè Chambost, Beatrice Nolan, Carolyn M. Bennett, Tadashi Matsushita, Bent Winding, Joachim Fruebis, Huixing Yuan, Dan Rudin, Johannes Oldenburg

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B

    Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B Autor John Pasi, Kathelijn Fischer, Margaret V. Ragni, B. Nolan, David J. Perry, Roshni Kulkarni, Margareth C. Ozelo, Johnny Mahlangu, Amy D. Shapiro, Ross Baker, Carolyn M. Bennett, Christopher Barnes, Johannes Oldenburg, Tadashi Matsushita, Huixing Yuan, Alejandra Ramirez-Santiago, Glenn F. Pierce, Geoffrey Allen, Baisong Mei

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: